INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
University of Rennes 1
Rennes, FranciaPublicaciones en colaboración con investigadores/as de University of Rennes 1 (11)
2024
2023
-
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
Nature Reviews Gastroenterology and Hepatology, Vol. 20, Núm. 7, pp. 462-480
-
TGFβ-induced circLTBP2 predicts a poor prognosis in intrahepatic cholangiocarcinoma and mediates gemcitabine resistance by sponging miR-338-3p
JHEP Reports, Vol. 5, Núm. 12
2022
-
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions
Gut, Vol. 71, Núm. 8, pp. 1669-1683
2021
-
Zinc Finger E-Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor–Stroma Paracrine Signaling
Hepatology, Vol. 74, Núm. 6, pp. 3194-3212
2019
-
Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance
Liver International, Vol. 39, Núm. S1, pp. 43-62
2018
-
Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data
The Lancet Neurology, Vol. 17, Núm. 10, pp. 895-904
2016
2015
-
Whole-genome fingerprint of the DNA methylome during human B cell differentiation
Nature Genetics, Vol. 47, Núm. 7, pp. 746-756
2014
-
Flexible-dose oral paliperidone ER in non-acute schizophrenia previously unsuccessfully treated with oral risperidone
Clinical Practice, Vol. 11, Núm. 6, pp. 573-583